Publications en collaboration avec des chercheurs de Sun Yat-sen University (1)

2016

  1. 140PD: LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S117-S118